Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Love Pharma Inc ( (TSE:JOLT) ) has shared an announcement.
Jolt Health Inc. announced a consolidation of its common shares, approved by shareholders and its Board, to enhance flexibility for future financing opportunities. The consolidation will see a 20:1 share ratio change, reducing the number of shares and aligning warrants and options accordingly, pending Canadian Securities Exchange approval.
More about Love Pharma Inc
Jolt Health Inc. is a leading life sciences company focused on healthcare, biotechnology, and artificial intelligence. It holds exclusive licenses for innovative therapeutic and pharmaceutical products across Europe, the UK, and North America. The company is committed to transforming the healthcare industry through research, collaboration, and technological advancement.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$636.4K
See more data about JOLT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue